These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 19553377

  • 1. Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus.
    Yang DH, Chang DM, Lai JH, Lin FH, Chen CH.
    Rheumatology (Oxford); 2009 Sep; 48(9):1083-7. PubMed ID: 19553377
    [Abstract] [Full Text] [Related]

  • 2. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus.
    Liu CC, Manzi S, Kao AH, Navratil JS, Ruffing MJ, Ahearn JM.
    Arthritis Rheum; 2005 Oct; 52(10):3087-99. PubMed ID: 16200588
    [Abstract] [Full Text] [Related]

  • 3. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
    Manzi S, Navratil JS, Ruffing MJ, Liu CC, Danchenko N, Nilson SE, Krishnaswami S, King DE, Kao AH, Ahearn JM.
    Arthritis Rheum; 2004 Nov; 50(11):3596-604. PubMed ID: 15529364
    [Abstract] [Full Text] [Related]

  • 4. Platelet C4d is highly specific for systemic lupus erythematosus.
    Navratil JS, Manzi S, Kao AH, Krishnaswami S, Liu CC, Ruffing MJ, Shaw PS, Nilson AC, Dryden ER, Johnson JJ, Ahearn JM.
    Arthritis Rheum; 2006 Feb; 54(2):670-4. PubMed ID: 16447243
    [Abstract] [Full Text] [Related]

  • 5. Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
    Singh V, Mahoney JA, Petri M.
    J Rheumatol; 2008 Oct; 35(10):1989-93. PubMed ID: 18709693
    [Abstract] [Full Text] [Related]

  • 6. Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.
    Kao AH, Navratil JS, Ruffing MJ, Liu CC, Hawkins D, McKinnon KM, Danchenko N, Ahearn JM, Manzi S.
    Arthritis Rheum; 2010 Mar; 62(3):837-44. PubMed ID: 20187154
    [Abstract] [Full Text] [Related]

  • 7. Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.
    Kalunian KC, Chatham WW, Massarotti EM, Reyes-Thomas J, Harris C, Furie RA, Chitkara P, Putterman C, Gross RL, Somers EC, Kirou KA, Ramsey-Goldman R, Hsieh C, Buyon JP, Dervieux T, Weinstein A.
    Arthritis Rheum; 2012 Dec; 64(12):4040-7. PubMed ID: 22932861
    [Abstract] [Full Text] [Related]

  • 8. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH.
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [Abstract] [Full Text] [Related]

  • 9. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
    Lood C, Eriksson S, Gullstrand B, Jönsen A, Sturfelt G, Truedsson L, Bengtsson AA.
    Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
    [Abstract] [Full Text] [Related]

  • 10. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R, Sequeira W, Kokebie R, Mikolaitis RA, Fogg L, Finnegan A, Plaas A, Block JA, Jolly M.
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [Abstract] [Full Text] [Related]

  • 11. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sánchez-Guerrero J.
    Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
    [Abstract] [Full Text] [Related]

  • 12. Hyperprolactinemia in males with systemic lupus erythematosus.
    Mok CC, Lau CS, Lee KW, Wong RW.
    J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
    [Abstract] [Full Text] [Related]

  • 13. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD, Yount WJ, Walport MJ, Winfield JB, Parker CJ, Fuller CR, Taylor RP, Myones BL, Lachmann PJ.
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [Abstract] [Full Text] [Related]

  • 14. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK.
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.
    Li J, An L, Zhang Z.
    Clin Exp Rheumatol; 2014 May; 32(1):48-53. PubMed ID: 23981509
    [Abstract] [Full Text] [Related]

  • 16. Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: a pilot study.
    Batal I, Liang K, Bastacky S, Kiss LP, McHale T, Wilson NL, Paul B, Lertratanakul A, Ahearn JM, Manzi SM, Kao AH.
    Lupus; 2012 Jan; 21(1):13-26. PubMed ID: 21959138
    [Abstract] [Full Text] [Related]

  • 17. Correlation of serum measures of nitric oxide production with lupus disease activity.
    Gilkeson G, Cannon C, Oates J, Reilly C, Goldman D, Petri M.
    J Rheumatol; 1999 Feb; 26(2):318-24. PubMed ID: 9972965
    [Abstract] [Full Text] [Related]

  • 18. Glomerular c4d staining can be an indicator of disease activity in lupus nephritis.
    Sahin OZ, Gurses S, Taslı F, Yavas H, Ersoy R, Uzum A, Cirit M.
    Ren Fail; 2013 Feb; 35(2):222-5. PubMed ID: 23176021
    [Abstract] [Full Text] [Related]

  • 19. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE, Sturgess AD, Davies MJ.
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [Abstract] [Full Text] [Related]

  • 20. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
    Petri M, Stohl W, Chatham W, McCune WJ, Chevrier M, Ryel J, Recta V, Zhong J, Freimuth W.
    Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.